Tenajora, Merina A.
HRN: 06-15-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/25/2023
10/02/2023
IV
2.25gm
Q6H
CAP MR; PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes